# Multicentric Study on Clopidogrel Resistance in DAPT for CAS (MULTI-RESCLOSA)

> **NCT05566301** · — · RECRUITING · sponsor: **IRCCS Policlinico S. Donato** · enrollment: 1140 (estimated)

## Conditions studied

- Clopidogrel, Poor Metabolism of
- Carotid Stenosis

## Interventions

- **DRUG:** Clopidogrel
- **DRUG:** Ticagrelor

## Key facts

- **NCT ID:** NCT05566301
- **Lead sponsor:** IRCCS Policlinico S. Donato
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-09-02
- **Primary completion:** 2026-09-30
- **Final completion:** 2026-12-31
- **Target enrollment:** 1140 (ESTIMATED)
- **Last updated:** 2025-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05566301

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05566301, "Multicentric Study on Clopidogrel Resistance in DAPT for CAS (MULTI-RESCLOSA)". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT05566301. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*